Prospective Study
Copyright ©The Author(s) 2017.
World J Crit Care Med. Feb 4, 2017; 6(1): 79-84
Published online Feb 4, 2017. doi: 10.5492/wjccm.v6.i1.79
Table 1 Demographic data of the groups with and without hospital acquired infections
FeaturesHAI (n = 76)No HAI (n = 420)P value
Age, mean (SD), (yr)39.4 (16.2)42.9 (16.5)0.04
Male:female46:30241:1790.70
APACHE II score, mean (SD)14.01 (4.7)13.9 (6.0)0.58
Diagnosis n (%)
Sepsis (including scrub typhus)27 (35.5)195 (46.4)
Deliberate self-harm30 (39.4)99 (23.6)
Cardiac4 (5.3)34 (8.1)0.11
Acute respiratory distress syndrome5 (6.6)28 (6.7)
Neurological6 (7.9)43 (10.2)
Others4 (5.3)21 (5.0)
Table 2 Impact of hospital-acquired infections on outcomes
OutcomeHAI (n = 76)No HAI (n = 420)P value
ICU length of stay, mean (SD), (d)13.4 (7.0)6.7 (4.5)< 0.01
Hospital stay, mean (SD), (d)21.8 (13.9)12.4 (8.2)< 0.001
In-hospital mortality31.60%27.20%0.49
Mortality with VAP126%27.2%21.0
Mortality due to BSI137%27.2%20.24
CAUTI mortality133%27.2%21.0
Table 3 Comparison of overall cost between those with infection and those without infection
TypeHAI (n = 76)No HAI1 (n = 420)Cost differenceP value
Mean (SD) cost (INR)
Any infection226398 (226268)115058 (93754)111340< 0.0001
VAP235350 (253421)115058 (93754)120292< 0.001
BSI283887 (341916)115058 (93754)168829< 0.001
CAUTI190059 (34096)115058 (93754)1559630.05
Median (IQR) cost (INR)
Any infection180469 (140030-237525)92875 (57243-139104)87594< 0.0001
VAP182991 (133038-238952)92875 (57243-139104)90116< 0.0001
BSI170753 (141788-238650)92875 (57243-139104)77878< 0.0001
CAUTI173085 (155818-190352)92875 (57243-139104)802100.06